AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

 Resonsible China Clinical Pharmacology strategy (including intensive PK, popPK, PK/PD, E-R, Immunogencitiy and QT analysis) to ensure: 1) smooth opening of late phase study in China; 2) relevant China CP regulation is fullfilled for a successful NDA registration  Serves as the clinical pharmacology representative in assigned China ASTs/IEST and TARM meetings  Serves as the (China) clinical pharmacology representative in assigned (global) study teams, to faciliate study execution  Work closely with related asset global Clin Pharm representatives in timely exchanging the relevant information and provide advise/input from the Chinese regulatory and scientific perspectives to support asset China CP strategy and study execution  Serves as the subject of expert of CP in China with close connection with global CP for professional support and collaboration  A critical reviewer and contributor for China CP documents for CTA and NDA submission, such as China PK study protocol/report/summary, related population PK report, exposure/response analysis report etc.  A key contributor/reviewer for CP part of local CDE consultation related documents (e.g. briefing book, CDE response letter), and CP part of CTA and NDA submission document (e.g. China specific clinical overview, IB and CTD, dose justification, study design justfication/China development plan).  Participate in local CDE consultation meetings and facilitate CP related communication with regulatory agency  Scienficly interpret CDE’s CP requirement in e.g. pre-CTA response, CTA letter, query/deficiency letter during NDA (working together with RA, CPPM and CD), ensure CDE’s requirement is implemented/fulfilled to derisk for regulatory activities.  Mangement of local KOLs  Manage related communications and collaborations between China AST and global AST/IEST in collaboration with the global CP counterparts

  Master or above degree in pharmacy, pharmacology, biology, medicine or related area, with Ph.D. preferred  0 year or more experience in clinical pharmacology in industry with PhD, 4-year or more experience in clinical pharmacology in industry with Master degree.  Good interpersonal skills, and ability to effectively interact with internal and external stake holders  Knowledge of strategic thinking  High proficiency in written and spoken English communication skills  Experience of working in MNCs is preferred

AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community.  Equal Opportunity Employer/Veterans/Disabled. 

US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html

US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:

https://www.abbvie.com/join-us/reasonable-accommodations.html